1x03 - The Nurses’ voice on Biosimilar medicines. An opportunity for integrated care
Conversations on the EU Pharma
Medicines for Europe
0 • 0 Ratings
🗓️ 3 October 2022
⏱️ 19 minutes
🧾️ Download transcript
Summary
Conversations on EU Pharma is back with a third episode we will explore the role played by specialised nurses in delivering positive patient outcomes with biologic therapies and the development of integrated care for patients living with Non-Communicable Diseases (NDC), starting with an overview on the impacts of Covid-19 on the nursing community.
Joining the discuss on the benefits of Biosimilar Medicines were:
- Adriano Friganovic, President of the European Specialist Nurses Organisation - ESNO
- Hanneke Voorneveld-Nieuwenhuis, Nurse Practitioner, Maasstad hospital, The Netherlands
As the host for this episode you will find Kate O’Regan, Communications & Stakeholder Relations Senior Manager from Medicines for Europe.
If would like to know more about this topic, you can dive into the resources mentioned during this episode:
- Nurses’ Knowledge and Attitudes towards Biosimilar Medicines as Part of Evidence-Based Nursing Practice—International Pilot Study within the Project Biosimilars Nurses
- The Non-medical Switch from Reference Adalimumab to Biosimilar Adalimumab is Highly Successful in a Large Cohort of Patients with Stable Inflammatory Rheumatic Joint Diseases: A Real-Life Observational Study
- A Communication and Information guide for nurses: Switch Management between Similar Biological Medicines
Listen to the episode on:
Amazon Music – Apple Podcast – Castbox – Google Podcasts – OverCast – Pocket Casts – RadioPublic – YouTube – Spotify – Stitcher
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello and welcome to Conversations on EU Pharma, a podcast by Medicines for Europe where we discuss the |
| 0:14.3 | challenges, opportunities and solutions for better health and better access for patients in Europe. |
| 0:20.6 | Today we're discussing the role of biosimilar medicines and how that can assist patient care |
| 0:25.9 | and those with non-communicable diseases, which are very prevalent and very burdensome in Europe. |
| 0:31.8 | I'm very pleased to be joined by two experts from the nursing community today, who I last |
| 0:36.8 | to introduce themselves. So maybe |
| 0:38.8 | Adriano, would you like to say a word of introduction? Well, hello everyone. My name is Adriano Fregano, |
| 0:44.6 | which I'm a president of the European Specialist Nursing Organization. I'm a critical care nurse. |
| 0:50.8 | I work at the University of Applied Health Sciences and University Hospital Center, |
| 0:56.9 | Zagreb, as head nurse of the Department of Anesthesiology and Intensive Care. I have a PhD in |
| 1:03.7 | public health, and I also serve as a president of the World Federation of Critical Care Nurses, I'm very happy to be here today with you. |
| 1:13.1 | Breeze, thank you Adriano. And Hanukkah? |
| 1:15.6 | Hello, everyone. I'm Hanukkah Fornefeld. |
| 1:18.6 | I work as a nurse practitioner in an outpatient clinic in the Netherlands, |
| 1:23.6 | within the field of rheumatology, and we do a lot of work with biologics and biosimilars and we did |
| 1:29.9 | some research on changing from originators to biosimilars. So I'm very pleased to be part of this |
| 1:38.4 | conversation. Thank you, Anka. I'm very happy to have both of you with us today. I think if we |
| 1:43.7 | jump straight in, I'd like to maybe start |
| 1:45.7 | both of you are practicing nurses within a hospital in your respective countries. And I'd really like to |
| 1:52.0 | start by asking, you know, from the nursing perspective, how is the situation in the hospitals now from |
| 1:57.7 | recovering from the pandemic and trying to rebuild patient care. |
| 2:02.4 | How has this period of time impacted the nursing community from your experience? |
... |
Transcript will be available on the free plan in -910 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Medicines for Europe, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medicines for Europe and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.